FIELD: chemistry.
SUBSTANCE: method involves conjugation of r-metHuG-CSF with PEG-aldehyde at the free amino group at the N-end of r-metHuG-CSF in the presence of a reducing agent in a buffer solution for pegylation, which contains a polyol of formula CnH2n+2On, where n equals 3-6, or carbohydrate or derivative thereof, where concentration of said polyol or carbohydrate or derivative thereof is in the range of 0.1%-10%, wt/wt.
EFFECT: high output of the r-metHuG-CSF pegylation reaction.
15 cl, 12 dwg, 1 tbl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
IMPROVED METHOD FOR PHYSIOLOGICALLY ACTIVE POLYPEPTIDE CONJUGATE PRODUCTION | 2013 |
|
RU2639256C2 |
PURIFICATION OF PEGYLATED POLYPEPTIDES | 2008 |
|
RU2476439C2 |
CHROMATOGRAPHIC METHODS | 2008 |
|
RU2464066C2 |
METHOD OF PURIFYING PEGYLATED ERYTHROPOIETIN | 2011 |
|
RU2566267C2 |
POLYETHYLENE GLYCOL DERIVATIVES CONTAINING AROMATIC DIAZO GROUP | 2010 |
|
RU2439091C1 |
POLYETHYLENE GLYCOL DERIVATIVE OF NEUROTROPHIC FACTOR POLYPEPTIDE AND METHOD OF PREPARATION THEREOF | 1995 |
|
RU2136694C1 |
PEG DENDRIMER WITH FOUR BRANCHES FOR CONJUGATION WITH PROTEINS AND PEPTIDES | 2006 |
|
RU2409389C2 |
NOVEL FUNCTIONALLY ACTIVE, HIGHLY PURE, STABLE CONJUGATE OF INTERFERON α WITH POLYETHYLENE GLYCOL, REPRESENTED BY ONE PEG- NH-IFN POSITIONAL ISOMER, WITH IMPROVED IMMUNOGENICITY, WITH PROLONGED BIOLOGICAL ACTION, SUITABLE FOR MEDICAL APPLICATION, AND IMMUNOLOGICAL AGENT BASED THEREON | 2010 |
|
RU2447083C1 |
SITE-SPECIFIC MONOPHYLATED ANALYGES OF EXCENDIN AND THE METHOD OF THEIR PRODUCTION | 2012 |
|
RU2625015C2 |
CONJUGATES OF BLOOD COAGULATION PROTEINS | 2010 |
|
RU2595442C2 |
Authors
Dates
2013-01-20—Published
2009-05-04—Filed